Ann‐Mari Forsblom

Lenalidomide inhibits the malignant clone and up-regulates the <i>SPARC</i> gene mapping to the commonly deleted region in 5q− syndrome patients

Andrea Pellagatti, Martin Jädersten, Ann‐Mari Forsblom et al. · Proceedings of the National Academy of Sciences · 2007 · 230 citations · Full text

Medicine, Hematology, Pharmacology +17

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors

Ramin Tehranchi, Bengt Fadeel, Ann‐Mari Forsblom et al. · Blood · 2003 · 130 citations · Full text

Life Sciences, Cell Biology, Hematology +13

A predictive model for the clinical response to low dose ara‐<i>C</i>: a study of 102 patients with myelodysplastic syndromes or acute leukaemia

Eva Hellström‐Lindberg, Karl‐Henrik Robèrt, Gösta Gahrton et al. · British Journal of Haematology · 1992 · 79 citations

Medicine, Hematology, Pharmacotherapy +17

Antiapoptotic Role of Growth Factors in the Myelodysplastic Syndromes: Concordance Between <i>In vitro</i> and <i>In vivo</i> Observations

Ramin Tehranchi, Bengt Fadeel, Jan Schmidt‐Mende et al. · Clinical Cancer Research · 2005 · 41 citations

Medicine, Hematology, Pathobiology +15

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G‐CSF

Maryam Nikpour, Andrea Pellagatti, Anquan Liu et al. · British Journal of Haematology · 2010 · 37 citations

Medicine, Cell Biology, Hematology +16